Treatment and Prevention of Cytomegalovirus Infections

  • Monto Ho
Part of the Current Topics in Infectious Disease book series (CTID)


Treatment of systemic virus diseases is still largely in the experimental stage, although rapid progess is being made. The basic problem has been that putative antiviral agents are either not effective enough or are too toxic. Evaluation of the effect of these drugs is also difficult. Frequently, the disease that is treated has a variable course, and the demonstration of efficacy of an antiviral may not be possible except by a blind, controlled study in which the drug-treated group is compared to a placebo-treated group. Such studies are expensive to undertake, and although the knowledge gained is usually solid, it is often limited.


Vaccine Strain Live Vaccine Strain Hamster Embryo Cell Adenine Arabinoside Respiratory Syncytial Virus Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • Monto Ho
    • 1
    • 2
  1. 1.Graduate School of Public Health and School of MedicineUniversity of PittsburghUSA
  2. 2.Presbyterian — University HospitalPittsburghUSA

Personalised recommendations